Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and fk 453

1,3-dipropyl-8-cyclopentylxanthine has been researched along with fk 453 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahane, A; Katayama, H; Kato, T; Kinoshita, T; Kita, Y; Kusunoki, T; Mitsunaga, T; Shiokawa, Y; Terai, T; Yoshida, K1
Akahane, A; Durkin, K; Itani, H; Kinoshita, T; Kuroda, S; Nishimura, S; Sakane, K; Tenda, Y1
El-Tayeb, A; Inamdar, GS; Li, W; Müller, CE; Scheiff, AB; Sudarsanam, V; Vasu, KK; Yerande, SG1
Herzer, WA; Jackson, EK; Kuan, CJ2

Other Studies

5 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and fk 453

ArticleYear
Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity.
    Journal of medicinal chemistry, 1999, Mar-11, Volume: 42, Issue:5

    Topics: Administration, Oral; Animals; Diuretics; Drug Design; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

1999
Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist.
    Bioorganic & medicinal chemistry letters, 1999, Jul-19, Volume: 9, Issue:14

    Topics: Antihypertensive Agents; Inhibitory Concentration 50; Molecular Structure; Piperidines; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Receptors, Purinergic P1; Solubility; Structure-Activity Relationship; Water; Xanthines

1999
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Adenosine A1 Receptor Antagonists; Animals; Drug Design; Humans; Molecular Structure; Rats; Receptor, Adenosine A1; Stereoisomerism; Structure-Activity Relationship; Thiazoles

2010
An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:2

    Topics: Adenosine; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Male; Phenethylamines; Purinergic Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Stereoisomerism; Xanthines

1992
Cardiovascular and renal effects of blocking A1 adenosine receptors.
    Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:5

    Topics: Animals; Antihypertensive Agents; Diuresis; Hemodynamics; Hemolysis; Male; Natriuresis; Purinergic Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Renal Circulation; Xanthines

1993